ROUVERPA financials
A multi-period view of the public annual-account figures reported for ROUVERPA, with comparable measures and links to available source documents.
Company overviewRegistry number
0441926159
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 30, 2026
Financial evidence
Latest movements for ROUVERPA
2025 versus 2024
- Operating line
- €46,447
- EBITDA
- €38,615
- Total assets
- €685,250
- Equity
- €401,356
-30.2%
-34.3%
+2.7%
+3.7%
EBITDA margin +83.1% · Equity ratio +58.6%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Jun 2025 | €46,447 | €38,615 | €685,250 | €401,356 | - |
| 202430 Jun 2024 | €66,531 | €58,807 | €667,034 | €387,142 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.